Dabigatran Capsule
Product Images NDC 60687-963

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Dabigatran (NDC 60687-963). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

150 mg Dabigatran Etexilate Capsule Blister.jpg (150 mg Dabigatran Etexilate Capsule Blister)

FDA Label Image

150 mg Dabigatran Etexilate Capsules Carton.jpg (150 mg Dabigatran Etexilate Capsules Carton)

This text provides information about Dabigatran Etexilate capsules, including details on dosage, how to store the medication, and important warnings. It emphasizes the need to dispense a Medication Guide to each patient and not to substitute these capsules with other Dabigatran Etexilate dosages. The text also specifies the content of each capsule and instructions for usage. Additionally, it mentions that the product should be stored at a temperature between 20° to 25°C and must be used within 4 months if taken out of the original blister packaging. The text concludes with details of the distributor, American Health Packaging.*

FDA Label Image

75 mg Dabigatran Etexilate Capsule Blister.jpg (75 mg Dabigatran Etexilate Capsule Blister)

FDA Label Image

75 mg Dabigatran Etexilate Capsules Carton.jpg (75 mg Dabigatran Etexilate Capsules Carton)

This text is a description of a medication named Dabigatran Etexilate which comes in capsule form and is used to prevent clotting. The capsules contain a specific amount of dabigatran etexilate mesylate and should be swallowed whole. The usual dosage instructions and storage guidelines are also provided, along with a warning to not use the product if the blister pack is broken. Additionally, the manufacturer information is included at the end of the text.*

FDA Label Image

Ahp96321

FDA Label Image

Ahp97432

FDA Label Image

Dabigatran-etexilate-figure-1 (Dabigatran Etexilate Figure 1)

FDA Label Image

Dabigatran-etexilate-figure-2 (Dabigatran Etexilate Figure 2)

FDA Label Image

Figure 3.1 (Dabigatran Etexilate Figure 3 1)

FDA Label Image

Figure 3.2 (Dabigatran Etexilate Figure 3 2)

The text appears to be a list of interacting drugs, dosages, and related terms such as PK (pharmacokinetics), AUC (area under the curve), Cmax (maximum concentration), and 90% confidence intervals for fold change relative to reference. It also mentions time differences for drug administration schedules.*

FDA Label Image

Dabigatran-etexilate-figure-4 (Dabigatran Etexilate Figure 4)

FDA Label Image

Dabigatran-etexilate-figure-5 (Dabigatran Etexilate Figure 5)

FDA Label Image

Dabigatran-etexilate-structure (Dabigatran Etexilate Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.